Zydus Wellness Limited (ZYDUSWELL) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Zydus Wellness develops and markets consumer wellness brands — Complan, Glucon-D, Sugar Free, Nycil, Everyuth and the newly acquired UK-based Comfort Click portfolio — and heads into its September quarter with milk input costs rising and seasonal brands still recovering from a weak summer. The print will speak to two things: whether the Comfort Click acquisition keeps delivering double-digit international growth and EPS accretion despite its fixed-cost load in a seasonally weak quarter, and how the guided ~66-67% gross margin holds up against the quarter's dairy inflation.

Zydus Wellness Limited Q2 Results Date and Time

The board of Zydus Wellness will meet on November 3, 2026, to approve the unaudited financial results for the quarter and half year ended September 30, 2026. The trading window remains closed until November 5 and reopens on November 6, 2026.

The Q2 FY27 earnings conference call is scheduled for November 3, 2026, at 4:00 p.m. IST, organized by ICICI Securities following the results. CEO Tarun Arora and CFO Umesh Parikh will represent the company.

What to expect from Zydus Wellness Limited's Q2 FY27 results

The September quarter is seasonally the smallest for Zydus Wellness, and the YoY comparison is acquisition-aided by construction — the Q2 FY26 base of Rs. 6,429 Mn net sales included only one month and two days of Alidac UK, so Comfort Click consolidation will flatter headline growth. The bigger test is domestic and seasonal: domestic grew only 4.6% in Q1 FY27, seasonal brands (Glucon-D, Nycil) fell 12.0%, and the East & Northeast region that drove the Glucon-D decline recorded its lowest monsoon since 1901, though management has said it anticipates positive growth momentum for the remainder of the financial year. On costs, milk inflation ran through the quarter — Mumbai wholesale prices rose Rs. 9 per litre to Rs. 102/litre effective September 1, 2026, and Tamil Nadu procurement prices were hiked twice in August from Rs. 38 to Rs. 44/litre — pressuring the path toward the guided ~66% to 67% annualized gross margin, with inventories of Rs. 763.8 Cr against ~Rs. 1,430 Cr of quarterly sales meaning the input move passes through quickly. Below gross margin, the structure is unchanged: ~Rs. 40 crores per quarter of acquired-brands amortization (Rs. 490 Mn in Q1 FY27), finance costs on the Euro-refinanced acquisition debt (Rs. 263 Mn in Q1 FY27), and Comfort Click's fixed-cost load — interest plus depreciation of roughly Rs. 80-85 crores per quarter per an analyst's computation, which management confirmed impacts EBITDA in the September and December quarters — against base-business quarterly margins the company sizes at just Rs. 10-15 crores. The upcoming call will likely cover the seasonal-recovery narrative, milk pass-through via pricing and mix, the Comfort Click scorecard, and whether the promised Domestic/International segment disclosure debuts this quarter.

Key Things To Watch

Performance vs guidance tracking: Management has a live scoreboard of stated targets — here is where each stood heading into the print.

• Base business EBITDA margin — 17%-18% over the next two years — reaffirmed Q4 FY26: 'there are no new numbers. We've talked about in the next couple of years, we hope to get to our 17-18. Now we have without Comfort Click. So those numbers stay'
• Comfort Click EBITDA margin — 14%+ on an annual basis over the next 1-2 years — was 'meeting or slightly exceeding EBITDA margin expectations' as of Q4 FY26
• Comfort Click EPS accretion — EPS-accretive since Q4 FY26; guidance maintained for the next two years
• RiteBite Max Protein revenue — INR 500 crores aspirational mark within the next two years
• Distribution availability — 3 million outlets, then 3.5 million and beyond — no public update since Q2 FY26
• Consolidated gross margin — ~66% to 67% annualized, excluding seasonality — open-ended guidance most directly exposed to the quarter's milk inflation

Seasonal brands trajectory and Comfort Click fixed-cost drag: The September quarter is seasonally small for Glucon-D and Nycil, and Comfort Click's fixed costs weigh on consolidated EBITDA in Sept/Dec quarters.

• Seasonal brands fell 12.0% in Q1 FY27 on a delayed summer; management anticipates positive growth momentum for the remainder of the financial year — watch whether that narrative is maintained
• Comfort Click fixed costs of close to INR 80-85 crores (interest plus depreciation, per an analyst's computation) against seasonally weak September and December quarters; management confirmed the EBITDA impact in those quarters
• Base-business margins are thin at INR 10-15 crores quarterly, so INR 5-8 crores of expense can move the quarterly margin by 30%-40%

Comfort Click growth, expansion and disclosures: The UK acquisition is now roughly one-third of consolidated revenue, and analysts have repeatedly pressed for more disclosure.

• Watch whether top-line growth remains in 'good double-digits' and whether management begins any constant-currency disclosure — currently considered 'from maybe next year onwards' given 3%-4% annualized EUR/INR and GBP/INR depreciation
• U.S. entry (approvals and setup in progress) and Middle East expansion — management said it is too early to predict U.S. impact but current signs are positive; WeightWorld entered Walmart Marketplace (USA) and, with Maxmedix, the Noon platform (UAE)
• Management has declined separate Comfort Click quarterly numbers ('We don't give separate numbers'); watch whether the committed Domestic/International segmentation appears in Q2 FY27 reporting

Balance sheet, FSSAI matter and management transition: Acquisition debt, a pending regulatory review and commercial-leadership changes round out the watch list.

• Debt repayment progress on the ~Rs. 3,000 crore acquisition debt (5.5-7 year schedule); ZWL consolidated total debt stood at Rs. 3,203 crore as of Mar 31, 2026 vs Rs. 188 crore a year earlier, with the capital-structure decision deferred 'in a couple of quarters'
• FSSAI notice on alleged misleading product claims received Sept 24, 2026, answered Oct 4, 2026; the company told exchanges there is no material impact — watch for any update beyond that characterization
• New Chief Revenue Officer Kapil Sharma joined Sept 1, 2026; the CMO position was vacated Sept 18, 2026 with no successor disclosed — watch for commercial-organization updates